For Industry

Patient-Focused Drug Development: Disease Area Meetings Planned for Fiscal Years 2013-2015

Unless otherwise noted, this schedule is subject to change. Meeting information for each disease area will be posted as it becomes available. More information on the selection of disease areas for fiscal years 2013-2015 can be found in the Federal Register Notice (PDF - 111KB) published on April 11, 2013.

FDA has published a preliminary list of nominated disease areas for consideration in patient-focused drug development meetings during fiscal years 2016-2017.  More information can be found in the Federal Register Notice published on October 8, 2014.

Meetings Planned for FY 2015

  • Female Sexual Dysfunction: October 27-28, 2014
  • Breast Cancer: April 2, 2015
  • Chagas Disease: April 28, 2015
  • Alpha-1 Antitrypsin Deficiency
  • Irritable Bowel Syndrome, Gastroparesis, and Gastroesophageal Reflux Disease with Persistent Regurgitation Symptoms on Proton-pump Inhibitors
  • Parkinson’s Disease and Huntington’s Disease

Meetings Held in FY 2014


Meetings Held in FY 2013

 

Page Last Updated: 12/18/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.